Join our
Investor Newsletter

To receive Investor News as it is released please sign up

News Releases

Form 8 (DD) - Renalytix Plc - Replacement

April 30, 2024
RNS Number : 6762M Harwood Capital LLP 30 April 2024       AMENDMENT: THIS FORM REPLACES RNS NUMBER 9333G, ANNOUNCED ON 14 MARCH 2024 AT 15:38. CHANGE MADE TO SECTION 2b.     AMENDMENT: PLEASE DISREGARD THE RNS RELEASED ON 15 MARCH 2024 AT 12:05, RNS NUMBER 0829H,       FORM 8 (DD)   PUBLIC DEALING

Holding(s) in Company

April 30, 2024
RNS Number : 4878M Renalytix PLC 30 April 2024   TR-1: S tandard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS   (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)   i 1a. Identity of the issuer or the underlying issuer of existing

Form 8.3 - Renalytix plc

April 29, 2024
RNS Number : 4647M Renalytix PLC 29 April 2024   FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Full name of discloser: Icahn

Stifel Nicolaus Euro - Form 8.5 (EPT/RI) - Renalytix plc

April 29, 2024
RNS Number : 3854M Stifel Nicolaus Europe Limited 29 April 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Name

Admission of the First Tranche Placing Shares

April 29, 2024
RNS Number : 2850M Renalytix PLC 29 April 2024   Renalytix plc ("Renalytix" or the "Company")   Admission of the First Tranche Placing Shares   LONDON and SALT LAKE CITY -   29 April 2024   -   Renalytix plc   (NASDAQ: RNLX) (LSE: RENX)   confirms that, further to the announcements made on 12 March

Holding(s) in Company

April 26, 2024
RNS Number : 2943M Renalytix PLC 26 April 2024   S tandard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS 1a. Identity of the issuer or the underlying issuer of existing shares: Renalytix PLC 1b. Please indicate if the issuer is a non- UK issuer    (please mark with an "X"

Lombard Odier - Form 8.3 - Renalytix PLC

April 26, 2024
RNS Number : 2828M Lombard Odier Asset Mgt (Eur) Ltd. 26 April 2024   FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Full name of

Holding(s) in Company

April 26, 2024
RNS Number : 2815M Renalytix PLC 26 April 2024   TR-1: S tandard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS   (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing

Stifel Nicolaus Euro - Form 8.5 (EPT/RI) - Renalytix plc

April 26, 2024
RNS Number : 2067M Stifel Nicolaus Europe Limited 26 April 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Name

Form 8.3 - Renalytix PLC

April 26, 2024
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1.            KEY INFORMATION (a) Full name of discloser: Pentwater Capital Management LP (b) Owner or controller of
Displaying 41 - 50 of 411